Skip to main content
Top
Published in: Child's Nervous System 9/2017

01-09-2017 | Letter to the Editor

PHACE syndrome and cerebral cavernous malformations: association or simply microhemorrhages?

Authors: Mark D. Mamlouk, Mohit Maheshwari, Patricia E. Burrows, Dawn H. Siegel, Ilona J. Frieden, Beth A. Drolet, Christopher P. Hess

Published in: Child's Nervous System | Issue 9/2017

Login to get access

Excerpt

Dear Editor: …
Literature
1.
go back to reference Foster KA, Ares WJ, Tempel ZJ et al (2016) PHACE syndrome is associated with intracranial cavernous malformations. Childs Nerv Syst 32:1463–1469CrossRefPubMed Foster KA, Ares WJ, Tempel ZJ et al (2016) PHACE syndrome is associated with intracranial cavernous malformations. Childs Nerv Syst 32:1463–1469CrossRefPubMed
2.
go back to reference Niwa T, Aida N, Takahara T et al (2010) Imaging and clinical characteristics of children with multiple foci of microsusceptibility changes in the brain on susceptibility-weighted MRI. Pediatr Radiol 40:1657–1662CrossRefPubMed Niwa T, Aida N, Takahara T et al (2010) Imaging and clinical characteristics of children with multiple foci of microsusceptibility changes in the brain on susceptibility-weighted MRI. Pediatr Radiol 40:1657–1662CrossRefPubMed
3.
go back to reference Hess CP, Fullerton HJ, Metry DW et al (2010) Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 31:1980–1986CrossRefPubMed Hess CP, Fullerton HJ, Metry DW et al (2010) Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 31:1980–1986CrossRefPubMed
4.
go back to reference Garzon MC, Epstein LG, Heyer GL et al (2016) PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr 178:24-33.e22 Garzon MC, Epstein LG, Heyer GL et al (2016) PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr 178:24-33.e22
6.
go back to reference Schneble HM, Soumare A, Herve D et al (2012) Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke 43:3196–3199CrossRefPubMed Schneble HM, Soumare A, Herve D et al (2012) Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke 43:3196–3199CrossRefPubMed
7.
go back to reference Schwammenthal Y, Tanne D, Kurnik D (2013) Letter by Kurnik et al regarding article, “antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations”. Stroke 44:e52CrossRefPubMed Schwammenthal Y, Tanne D, Kurnik D (2013) Letter by Kurnik et al regarding article, “antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations”. Stroke 44:e52CrossRefPubMed
8.
go back to reference Flemming KD, Link MJ, Christianson TJ, Brown RD Jr (2013) Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg 118:43–46CrossRefPubMed Flemming KD, Link MJ, Christianson TJ, Brown RD Jr (2013) Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg 118:43–46CrossRefPubMed
Metadata
Title
PHACE syndrome and cerebral cavernous malformations: association or simply microhemorrhages?
Authors
Mark D. Mamlouk
Mohit Maheshwari
Patricia E. Burrows
Dawn H. Siegel
Ilona J. Frieden
Beth A. Drolet
Christopher P. Hess
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 9/2017
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3479-x

Other articles of this Issue 9/2017

Child's Nervous System 9/2017 Go to the issue